Carbaglu - 52276-312-05 - (Carglumic Acid)

Alphabetical Index


Drug Information of Carbaglu

Product NDC: 52276-312
Proprietary Name: Carbaglu
Non Proprietary Name: Carglumic Acid
Active Ingredient(s): 200    mg/1 & nbsp;   Carglumic Acid
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Carbaglu

Product NDC: 52276-312
Labeler Name: Orphan Europe, SARL
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022562
Marketing Category: NDA
Start Marketing Date: 20100318

Package Information of Carbaglu

Package NDC: 52276-312-05
Package Description: 5 TABLET in 1 BOTTLE (52276-312-05)

NDC Information of Carbaglu

NDC Code 52276-312-05
Proprietary Name Carbaglu
Package Description 5 TABLET in 1 BOTTLE (52276-312-05)
Product NDC 52276-312
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carglumic Acid
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20100318
Marketing Category Name NDA
Labeler Name Orphan Europe, SARL
Substance Name CARGLUMIC ACID
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Carbamoyl Phosphate Synthetase 1 Activator [EPC],Carbamoyl Phosphate Synthetase 1 Activators [MoA]

Complete Information of Carbaglu


General Information